AGILENT TECHNOLOGIES INC (A) Stock Fundamental Analysis
NYSE:A - New York Stock Exchange, Inc. - US00846U1016 - Common Stock - Currency: USD
We assign a fundamental rating of 6 out of 10 to A. A was compared to 56 industry peers in the Life Sciences Tools & Services industry. A gets an excellent profitability rating and is at the same time showing great financial health properties. A has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year A was profitable.
In the past year A had a positive cash flow from operations.
In the past 5 years A has always been profitable.
In the past 5 years A always reported a positive cash flow from operatings.
1.2 Ratios
A has a Return On Assets of 10.57%. This is amongst the best in the industry. A outperforms 89.29% of its industry peers.
The Return On Equity of A (20.89%) is better than 92.86% of its industry peers.
Looking at the Return On Invested Capital, with a value of 13.70%, A belongs to the top of the industry, outperforming 89.29% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for A is in line with the industry average of 12.97%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.57% | ||
| ROE | 20.89% | ||
| ROIC | 13.7% |
ROA(3y)11.44%
ROA(5y)10.62%
ROE(3y)22.24%
ROE(5y)20.78%
ROIC(3y)14.65%
ROIC(5y)13.29%
1.3 Margins
The Profit Margin of A (19.27%) is better than 94.64% of its industry peers.
A's Profit Margin has been stable in the last couple of years.
With an excellent Operating Margin value of 23.79%, A belongs to the best of the industry, outperforming 92.86% of the companies in the same industry.
A's Operating Margin has improved in the last couple of years.
With a decent Gross Margin value of 54.17%, A is doing good in the industry, outperforming 64.29% of the companies in the same industry.
In the last couple of years the Gross Margin of A has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 23.79% | ||
| PM (TTM) | 19.27% | ||
| GM | 54.17% |
OM growth 3Y4.07%
OM growth 5Y5.41%
PM growth 3Y1.12%
PM growth 5Y-0.93%
GM growth 3Y0.36%
GM growth 5Y0.01%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so A is still creating some value.
Compared to 1 year ago, A has less shares outstanding
The number of shares outstanding for A has been reduced compared to 5 years ago.
The debt/assets ratio for A is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 4.61 indicates that A is not in any danger for bankruptcy at the moment.
A has a Altman-Z score of 4.61. This is amongst the best in the industry. A outperforms 83.93% of its industry peers.
The Debt to FCF ratio of A is 2.56, which is a good value as it means it would take A, 2.56 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 2.56, A belongs to the best of the industry, outperforming 82.14% of the companies in the same industry.
A Debt/Equity ratio of 0.56 indicates that A is somewhat dependend on debt financing.
The Debt to Equity ratio of A (0.56) is worse than 64.29% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.56 | ||
| Debt/FCF | 2.56 | ||
| Altman-Z | 4.61 |
ROIC/WACC1.33
WACC10.28%
2.3 Liquidity
A Current Ratio of 2.20 indicates that A has no problem at all paying its short term obligations.
The Current ratio of A (2.20) is comparable to the rest of the industry.
A Quick Ratio of 1.66 indicates that A should not have too much problems paying its short term obligations.
A has a Quick ratio (1.66) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.2 | ||
| Quick Ratio | 1.66 |
3. Growth
3.1 Past
The earnings per share for A have decreased by -1.12% in the last year.
Measured over the past years, A shows a quite strong growth in Earnings Per Share. The EPS has been growing by 11.14% on average per year.
Looking at the last year, A shows a decrease in Revenue. The Revenue has decreased by -3.00% in the last year.
Measured over the past years, A shows a small growth in Revenue. The Revenue has been growing by 4.75% on average per year.
EPS 1Y (TTM)-1.12%
EPS 3Y6.82%
EPS 5Y11.14%
EPS Q2Q%1.55%
Revenue 1Y (TTM)-3%
Revenue growth 3Y1%
Revenue growth 5Y4.75%
Sales Q2Q%1.39%
3.2 Future
Based on estimates for the next years, A will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.57% on average per year.
The Revenue is expected to grow by 5.89% on average over the next years.
EPS Next Y7.21%
EPS Next 2Y8.25%
EPS Next 3Y8.95%
EPS Next 5Y9.57%
Revenue Next Year3.9%
Revenue Next 2Y4.94%
Revenue Next 3Y5.41%
Revenue Next 5Y5.89%
3.3 Evolution
The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
A is valuated rather expensively with a Price/Earnings ratio of 20.86.
78.57% of the companies in the same industry are more expensive than A, based on the Price/Earnings ratio.
A is valuated rather cheaply when we compare the Price/Earnings ratio to 26.60, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 17.87, which indicates a rather expensive current valuation of A.
78.57% of the companies in the same industry are more expensive than A, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 22.43. A is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.86 | ||
| Fwd PE | 17.87 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, A is valued a bit cheaper than 78.57% of the companies in the same industry.
A's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. A is cheaper than 76.79% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 24.07 | ||
| EV/EBITDA | 18.8 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)2.9
PEG (5Y)1.87
EPS Next 2Y8.25%
EPS Next 3Y8.95%
5. Dividend
5.1 Amount
With a yearly dividend of 0.88%, A is not a good candidate for dividend investing.
A's Dividend Yield is rather good when compared to the industry average which is at 0.53. A pays more dividend than 100.00% of the companies in the same industry.
With a Dividend Yield of 0.88, A pays less dividend than the S&P500 average, which is at 2.36.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.88% |
5.2 History
The dividend of A is nicely growing with an annual growth rate of 7.63%!
A has paid a dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)7.63%
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
21.92% of the earnings are spent on dividend by A. This is a low number and sustainable payout ratio.
The dividend of A is growing, but earnings are growing more, so the dividend growth is sustainable.
DP21.92%
EPS Next 2Y8.25%
EPS Next 3Y8.95%
NYSE:A (5/21/2025, 11:00:05 AM)
110.77
-2.71 (-2.39%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners91.15%
Inst Owner Change0.2%
Ins Owners0.19%
Ins Owner Change1.72%
Market Cap31.58B
Analysts75.56
Price Target143.05 (29.14%)
Short Float %1.52%
Short Ratio1.93
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.88% |
Yearly Dividend0.95
Dividend Growth(5Y)7.63%
DP21.92%
Div Incr Years0
Div Non Decr Years0
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.35%
Min EPS beat(2)1.14%
Max EPS beat(2)1.57%
EPS beat(4)4
Avg EPS beat(4)1.49%
Min EPS beat(4)0.33%
Max EPS beat(4)2.92%
EPS beat(8)7
Avg EPS beat(8)1.45%
EPS beat(12)10
Avg EPS beat(12)2.6%
EPS beat(16)14
Avg EPS beat(16)3.55%
Revenue beat(2)0
Avg Revenue beat(2)-0.76%
Min Revenue beat(2)-1.23%
Max Revenue beat(2)-0.29%
Revenue beat(4)0
Avg Revenue beat(4)-1.19%
Min Revenue beat(4)-2.54%
Max Revenue beat(4)-0.29%
Revenue beat(8)2
Avg Revenue beat(8)-0.5%
Revenue beat(12)5
Avg Revenue beat(12)0.09%
Revenue beat(16)7
Avg Revenue beat(16)0.41%
PT rev (1m)-6.71%
PT rev (3m)-6.93%
EPS NQ rev (1m)-0.2%
EPS NQ rev (3m)-2.92%
EPS NY rev (1m)-0.21%
EPS NY rev (3m)-0.14%
Revenue NQ rev (1m)-0.06%
Revenue NQ rev (3m)-1.43%
Revenue NY rev (1m)-0.04%
Revenue NY rev (3m)-1.44%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 20.86 | ||
| Fwd PE | 17.87 | ||
| P/S | 4.83 | ||
| P/FCF | 24.07 | ||
| P/OCF | 18.61 | ||
| P/B | 5.24 | ||
| P/tB | 29.13 | ||
| EV/EBITDA | 18.8 |
EPS(TTM)5.31
EY4.79%
EPS(NY)6.2
Fwd EY5.6%
FCF(TTM)4.6
FCFY4.15%
OCF(TTM)5.95
OCFY5.37%
SpS22.91
BVpS21.14
TBVpS3.8
PEG (NY)2.9
PEG (5Y)1.87
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 10.57% | ||
| ROE | 20.89% | ||
| ROCE | 15.47% | ||
| ROIC | 13.7% | ||
| ROICexc | 16.03% | ||
| ROICexgc | 37.74% | ||
| OM | 23.79% | ||
| PM (TTM) | 19.27% | ||
| GM | 54.17% | ||
| FCFM | 20.08% |
ROA(3y)11.44%
ROA(5y)10.62%
ROE(3y)22.24%
ROE(5y)20.78%
ROIC(3y)14.65%
ROIC(5y)13.29%
ROICexc(3y)17.07%
ROICexc(5y)15.7%
ROICexgc(3y)42.54%
ROICexgc(5y)41.66%
ROCE(3y)16.57%
ROCE(5y)15.04%
ROICexcg growth 3Y-7.71%
ROICexcg growth 5Y-3.01%
ROICexc growth 3Y-0.19%
ROICexc growth 5Y4.58%
OM growth 3Y4.07%
OM growth 5Y5.41%
PM growth 3Y1.12%
PM growth 5Y-0.93%
GM growth 3Y0.36%
GM growth 5Y0.01%
F-Score5
Asset Turnover0.55
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.56 | ||
| Debt/FCF | 2.56 | ||
| Debt/EBITDA | 1.85 | ||
| Cap/Depr | 144.2% | ||
| Cap/Sales | 5.89% | ||
| Interest Coverage | 22.52 | ||
| Cash Conversion | 93.19% | ||
| Profit Quality | 104.21% | ||
| Current Ratio | 2.2 | ||
| Quick Ratio | 1.66 | ||
| Altman-Z | 4.61 |
F-Score5
WACC10.28%
ROIC/WACC1.33
Cap/Depr(3y)116.28%
Cap/Depr(5y)89.27%
Cap/Sales(3y)4.81%
Cap/Sales(5y)3.93%
Profit Quality(3y)102.27%
Profit Quality(5y)105.09%
High Growth Momentum
Growth
EPS 1Y (TTM)-1.12%
EPS 3Y6.82%
EPS 5Y11.14%
EPS Q2Q%1.55%
EPS Next Y7.21%
EPS Next 2Y8.25%
EPS Next 3Y8.95%
EPS Next 5Y9.57%
Revenue 1Y (TTM)-3%
Revenue growth 3Y1%
Revenue growth 5Y4.75%
Sales Q2Q%1.39%
Revenue Next Year3.9%
Revenue Next 2Y4.94%
Revenue Next 3Y5.41%
Revenue Next 5Y5.89%
EBIT growth 1Y13.76%
EBIT growth 3Y5.1%
EBIT growth 5Y10.42%
EBIT Next Year20.32%
EBIT Next 3Y12.15%
EBIT Next 5Y-0.19%
FCF growth 1Y23.66%
FCF growth 3Y1.94%
FCF growth 5Y9.68%
OCF growth 1Y25.43%
OCF growth 3Y5.65%
OCF growth 5Y11.39%